Androgen Deprivation Therapy (ADT) Market Size, Share, Growth, and Industry Analysis, By Type (Medicine, Surgery, Other), By Application (Hospital, Clinic, Other), Regional Insights and Forecast to 2035

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Androgen Deprivation Therapy (ADT) Market Size 2019-2030
2.1.2 Androgen Deprivation Therapy (ADT) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Androgen Deprivation Therapy (ADT) Segment by Type
2.2.1 Medicine
2.2.2 Surgery
2.2.3 Other
2.3 Androgen Deprivation Therapy (ADT) Market Size by Type
2.3.1 Androgen Deprivation Therapy (ADT) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Androgen Deprivation Therapy (ADT) Market Size Market Share by Type (2019-2024)
2.4 Androgen Deprivation Therapy (ADT) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Androgen Deprivation Therapy (ADT) Market Size by Application
2.5.1 Androgen Deprivation Therapy (ADT) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Androgen Deprivation Therapy (ADT) Market Size Market Share by Application (2019-2024)
3 Androgen Deprivation Therapy (ADT) Market Size by Player
3.1 Androgen Deprivation Therapy (ADT) Market Size Market Share by Players
3.1.1 Global Androgen Deprivation Therapy (ADT) Revenue by Players (2019-2024)
3.1.2 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Players (2019-2024)
3.2 Global Androgen Deprivation Therapy (ADT) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Androgen Deprivation Therapy (ADT) by Regions
4.1 Androgen Deprivation Therapy (ADT) Market Size by Regions (2019-2024)
4.2 Americas Androgen Deprivation Therapy (ADT) Market Size Growth (2019-2024)
4.3 APAC Androgen Deprivation Therapy (ADT) Market Size Growth (2019-2024)
4.4 Europe Androgen Deprivation Therapy (ADT) Market Size Growth (2019-2024)
4.5 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size Growth (2019-2024)
5 Americas
5.1 Americas Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024)
5.2 Americas Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024)
5.3 Americas Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Androgen Deprivation Therapy (ADT) Market Size by Region (2019-2024)
6.2 APAC Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024)
6.3 APAC Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Androgen Deprivation Therapy (ADT) by Country (2019-2024)
7.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024)
7.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Androgen Deprivation Therapy (ADT) by Region (2019-2024)
8.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024)
8.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Androgen Deprivation Therapy (ADT) Market Forecast
10.1 Global Androgen Deprivation Therapy (ADT) Forecast by Regions (2025-2030)
10.1.1 Global Androgen Deprivation Therapy (ADT) Forecast by Regions (2025-2030)
10.1.2 Americas Androgen Deprivation Therapy (ADT) Forecast
10.1.3 APAC Androgen Deprivation Therapy (ADT) Forecast
10.1.4 Europe Androgen Deprivation Therapy (ADT) Forecast
10.1.5 Middle East & Africa Androgen Deprivation Therapy (ADT) Forecast
10.2 Americas Androgen Deprivation Therapy (ADT) Forecast by Country (2025-2030)
10.2.1 United States Androgen Deprivation Therapy (ADT) Market Forecast
10.2.2 Canada Androgen Deprivation Therapy (ADT) Market Forecast
10.2.3 Mexico Androgen Deprivation Therapy (ADT) Market Forecast
10.2.4 Brazil Androgen Deprivation Therapy (ADT) Market Forecast
10.3 APAC Androgen Deprivation Therapy (ADT) Forecast by Region (2025-2030)
10.3.1 China Androgen Deprivation Therapy (ADT) Market Forecast
10.3.2 Japan Androgen Deprivation Therapy (ADT) Market Forecast
10.3.3 Korea Androgen Deprivation Therapy (ADT) Market Forecast
10.3.4 Southeast Asia Androgen Deprivation Therapy (ADT) Market Forecast
10.3.5 India Androgen Deprivation Therapy (ADT) Market Forecast
10.3.6 Australia Androgen Deprivation Therapy (ADT) Market Forecast
10.4 Europe Androgen Deprivation Therapy (ADT) Forecast by Country (2025-2030)
10.4.1 Germany Androgen Deprivation Therapy (ADT) Market Forecast
10.4.2 France Androgen Deprivation Therapy (ADT) Market Forecast
10.4.3 UK Androgen Deprivation Therapy (ADT) Market Forecast
10.4.4 Italy Androgen Deprivation Therapy (ADT) Market Forecast
10.4.5 Russia Androgen Deprivation Therapy (ADT) Market Forecast
10.5 Middle East & Africa Androgen Deprivation Therapy (ADT) Forecast by Region (2025-2030)
10.5.1 Egypt Androgen Deprivation Therapy (ADT) Market Forecast
10.5.2 South Africa Androgen Deprivation Therapy (ADT) Market Forecast
10.5.3 Israel Androgen Deprivation Therapy (ADT) Market Forecast
10.5.4 Turkey Androgen Deprivation Therapy (ADT) Market Forecast
10.5.5 GCC Countries Androgen Deprivation Therapy (ADT) Market Forecast
10.6 Global Androgen Deprivation Therapy (ADT) Forecast by Type (2025-2030)
10.7 Global Androgen Deprivation Therapy (ADT) Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Androgen Deprivation Therapy (ADT) Product Offered
11.1.3 Pfizer Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Information
11.2.2 Astellas Pharma Androgen Deprivation Therapy (ADT) Product Offered
11.2.3 Astellas Pharma Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Astellas Pharma Main Business Overview
11.2.5 Astellas Pharma Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Androgen Deprivation Therapy (ADT) Product Offered
11.3.3 Johnson & Johnson Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 Novartis International
11.4.1 Novartis International Company Information
11.4.2 Novartis International Androgen Deprivation Therapy (ADT) Product Offered
11.4.3 Novartis International Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novartis International Main Business Overview
11.4.5 Novartis International Latest Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Androgen Deprivation Therapy (ADT) Product Offered
11.5.3 Merck Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Merck Main Business Overview
11.5.5 Merck Latest Developments
11.6 Veru
11.6.1 Veru Company Information
11.6.2 Veru Androgen Deprivation Therapy (ADT) Product Offered
11.6.3 Veru Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Veru Main Business Overview
11.6.5 Veru Latest Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Androgen Deprivation Therapy (ADT) Product Offered
11.7.3 Sanofi Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Sanofi Main Business Overview
11.7.5 Sanofi Latest Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Information
11.8.2 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Product Offered
11.8.3 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 GlaxoSmithKline Main Business Overview
11.8.5 GlaxoSmithKline Latest Developments
11.9 Bayer
11.9.1 Bayer Company Information
11.9.2 Bayer Androgen Deprivation Therapy (ADT) Product Offered
11.9.3 Bayer Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Bayer Main Business Overview
11.9.5 Bayer Latest Developments
11.10 Orion
11.10.1 Orion Company Information
11.10.2 Orion Androgen Deprivation Therapy (ADT) Product Offered
11.10.3 Orion Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Orion Main Business Overview
11.10.5 Orion Latest Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Company Information
11.11.2 AstraZeneca Androgen Deprivation Therapy (ADT) Product Offered
11.11.3 AstraZeneca Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 AstraZeneca Main Business Overview
11.11.5 AstraZeneca Latest Developments
12 Research Findings and Conclusion